$TR

TOOTSIE ROLL INDUSTRIES INC (TR): Results of Operations and Financial Condition

TOOTSIE ROLL INDUSTRIES INC (TR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tr-20260722xex99d1.htm EX-99.1 Exhibit 99.1 ​ ​ TOOTSIE ROLL INDUSTRIES, INC. ​ ​ 7401 South Cicero Avenue ​ Chicago, IL 60629 ​ Phone 773/838-3400 ​ Fax 773/838-3534 ​ PRESS RELEASE ​ ​ ​ ​ ​ STOCK TRADED: NYSE FOR IMMEDIATE RELEASE TICKER SYMBOL: TR Wednesday, July 22

Original reporting
Published Jul 23, 2026, 3:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 23, 2026, 3:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$TR
Bearish
medium confidence
Mentioned
$TR
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$TRBearishMed
01

Why it matters

Earnings declined year over year, with management citing (1) seasonal sales timing between Q2 and Q3, (2) higher cocoa/chocolate unit costs pressuring gross margins, and (3) elevated energy, freight, resin-based packaging, marketing, and professional fees. Management also indicates cocoa/chocolate costs should be lower in 2H 2026 and into 2027 as supply-chain costs reflect market declines.

02

Market read

Traders can reassess near-term margin risk from cocoa and energy costs and the extent to which reported net sales weakness is timing and promotion accounting versus demand.

03

What to watch

Trade promotions reduce reported net sales, so reported top-line weakness may overstate underlying sell-through; also first-half sales were roughly flat while earnings fell, pointing to margin and expense mix rather than volume collapse.

Relevance 7/10Novelty 7/10Timing: after-hours SEC 8-K filed July 23, covering Q2 and first-half results

Background

This is an SEC Form 8-K with a press release covering Tootsie Roll’s Q2 2026 and first-half 2026 results and management commentary on drivers.

Company-level read

Ticker impact

$TRBearishMedium confidence
Context

Tootsie Roll reports Q2 2026 net sales of $151.943M and net earnings of $13.347M, both down year over year.

Expected impact

Near-term downside bias versus prior expectations, with some offset from management’s view that cocoa costs should normalize in 2H 2026 and into 2027.

Evidence & confidence

The filing provides concrete quarterly and half-year P&L figures plus management’s specific cost and timing drivers, but it does not include explicit forward guidance or a new forecast range.

Market effects

Highlights ongoing input-cost volatility (cocoa/chocolate) and the earnings impact of trade promotion accounting in packaged confectionery.

No specific regional breakdown beyond “unfavorable international results,” limiting geographic read-through.

Cocoa cost normalization expectations could influence sentiment for global confectionery peers with similar commodity exposure.

Counterpoint

The company frames cocoa cost relief as lagged into 2H 2026 and 2027, so the earnings miss may be more timing and cost-pass-through than demand deterioration.

Key entities

  • Tootsie Roll Industries, Inc.

    NYSE-listed confectionery company reporting Q2 and first-half 2026 sales and earnings, with commentary on cocoa/energy costs and trade promotion effects.

Related articles

$IPHAMed

Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript

Innate Pharma (IPHA) reported Q2 2026 earnings, highlighting a cash position of -€21.4M, a $75M upfront payment from Sobi, and -€28M in net equity proceeds. H1 2026 net loss was -€19.6M, with revenue of -€5.7M. The company extended its cash runway to Q1 2028 and anticipates key milestones, including a Phase 3 readout for monalizumab and initial data for IPH4502. Management expects to file for accelerated approval of lacutamab in Sezary Syndrome in H2 2027.

$UPXIMed

Upexi Inc (UPXI) (Q4 2026) Earnings Call Highlights: Massive Solana Treasury Fuels $246

Upexi Inc. (UPXI) reported Q4 2026 earnings, highlighting a $246M net loss driven by digital asset losses. CEO Alan Marshall discussed Solana treasury management, debt restructuring, and cost-cutting efforts. The company holds 2.34M Solana tokens, with staking revenue covering expenses. Management emphasized creative capital allocation and potential expansion in Asian markets through the Hivemind partnership. Stockholders' equity was negative $53.8M as of June 30, 2026.

$RBAMedAI 8/10

RB Global’s (RBA) Earnings Jump While Its Take Rate Shrinks

RB Global (RBA) reported Q2 earnings with net income up 33% YoY to $132M, EPS up 34% to $0.71, and revenue up 11% to $1.3B. Automotive segment drove GTV growth of 13%. Acquisitions boosted growth, but organic GTV growth was 7%. Service revenue take rate fell 110 bps to 20.0%. Management raised full-year guidance and increased the dividend. Hedge fund ownership declined, and short interest is high at 10.54% of float.

$CRBGMed

A GAAP Loss Masks What Corebridge (CRBG) Actually Earned This Quarter

Corebridge Financial (CRBG) reported a GAAP net loss of $16M for Q2, but adjusted operating income was $512M. Institutional Markets saw strong growth, while Individual Retirement segment declined. The company returned $412M to shareholders and approved a merger with Equitable Holdings. Adjusted pre-tax income fell 21%, and total premiums dropped 13%.

$JHXMedAI 8/10

James Hardie (JHX) Crushes Guidance and Raises Its Full-Year Outlook

James Hardie (JHX) reported Q1 FY2027 results with net sales up 64% YoY to $1.475B, adjusted EBITDA up 79% to $422.1M, and raised full-year guidance. The company cited strong execution, cost synergies from the AZEK acquisition, and share gains in its core business. CEO Aaron Erter noted the beat was not due to housing market improvement. Free cash flow doubled to $254.2M, used to pay down debt. Shares trade at a forward P/E of 21.79.

$JBHTMed

Why Investors Were Hitting the Brakes on J.B. Hunt Stock This Week

J.B. Hunt Transport Services (JBHT) stock fell over 12% after CFO Brad Delco forecasted a 5-10% sequential decline in Q3 net earnings due to rising diesel costs and driver expenses. Several analysts, including those at Wells Fargo and Bank of America, cut price targets but maintained buy ratings. Jeff Kauffman of Citizens upgraded the stock to a buy with a $300 target, citing temporary cost pressures.